Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults. Lumry W, Gunsior M, Cohen T, Bernard K, et al. Ann Allergy Asthma Immunol 2025;135:103-111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lumry W, Gunsior M, Cohen T, Bernard K, et al. Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults. Ann Allergy Asthma Immunol 2025;135:103-111.
PMID: 40158724